Related Experiment Video
Updated: Oct 19, 2025
06:57
Analysis of Transforming Growth Factor ß Family Cleavage Products Secreted Into the Blastocoele of Xenopus laevis Embryos
Published on: July 21, 2021
2.6K
Break Away: FKBP12 sequestration as a target for increasing BMP activity
Martha C Taubert1, Felix Hausch1
1Department of Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University Darmstadt, Alarich-Weiss Strasse 4, 64287 Darmstadt, Germany.
Cell Chemical Biology
|September 17, 2021
Summary
FKBP12 inhibition can treat acute kidney injury (AKI) by activating bone morphogenetic protein (BMP) signaling. This discovery offers a potential new therapeutic target for AKI, a widespread condition lacking effective treatments.
Area of Science:
- Biochemistry
- Nephrology
- Molecular Biology
Background:
- Bone morphogenetic protein (BMP) signaling plays a role in the development of acute kidney injury (AKI).
- Current treatment options for AKI are limited, highlighting the need for novel therapeutic strategies.
Purpose of the Study:
- To investigate FKBP12 inhibition as a potential therapeutic target for acute kidney injury (AKI).
- To explore the mechanism of FKBP12 inhibition in activating BMP signaling for AKI treatment.
Main Methods:
- The study involved investigating the effects of FKBP12 inhibition on BMP signaling pathways.
- Researchers analyzed the impact of these molecular changes in the context of acute kidney injury models.
Main Results:
- FKBP12 inhibition was found to activate BMP signaling.
- This activation demonstrated a therapeutic potential for treating acute kidney injury.
Conclusions:
- Inhibition of FKBP12 represents a promising therapeutic strategy for acute kidney injury.
- Targeting FKBP12 offers a novel approach to activating BMP signaling for AKI treatment.
